Plasma NGAL measured at the enrolment day was a good diagnostic marker for AKI development within the next 3 days (area under ROC: 0.80, 95% CI 0.70 - 0.89, p <0.001) and for RRT use (area under ROC: 0.81, 95% CI 0.75 - 0.85), p <0.001).